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Abstract
At the time of this writing, the coronavirus disease 2019 pandemic continues to be a global threat, disrupting usual processes, and protocols for delivering health care around the globe. There have been signiﬁcant regional and national differences in the scope and timing of these disruptions. Many hospitals were forced to temporarily halt elective
neurointerventional procedures with the ﬁrst wave of the pandemic in the spring of 2020, in order to prioritize allocation
of resources for acutely ill patients and also to minimize coronavirus disease 2019 transmission risks to non-acute patients,
their families, and health care workers. This temporary moratorium on elective neurointerventional procedures is generally
credited with helping to “ﬂatten the curve” and direct scarce resources to more acutely ill patients; however, there have been
reports of some delaying seeking medical care when it was in fact urgent, and other reports of patients having elective treatment delayed with the result of morbidity and mortality. Many regions have resumed elective neurointerventional procedures, only to now watch coronavirus disease 2019 positivity rates again climbing as winter of 2020 approaches. A new
wave is now forecast which may have larger volumes of hospitalized coronavirus disease 2019 patients than the earlier
wave(s) and may also coincide with a wave of patients hospitalized with seasonal inﬂuenza. This paper discusses relevant
and practical elements of cessation and safe resumption of nonemergent neurointerventional services in the setting of a
pandemic.
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Background
The coronavirus disease 2019 (COVID-19) virus was
identiﬁed in the human population in late 2019 and
rapidly spread across the globe. Although the case fatality
rate of the virus was unclear, the virus was recognized to
be highly transmissible. By March of 2019, many parts of
the world saw their hospitals and systems of health care
strained. Resources of intensive care unit (ICU) beds, ventilators, drugs (especially those used with ventilated
patients), and trained staff were in short supply for the
most acutely ill patients. Personal protective equipment
(PPE) necessary to protect non-COVID patients, health
care providers, and family members was also in short
supply. Many regions of the globe adopted protocols
created by governmental public health entities and major
physician organizations to cease all elective, non-urgent
procedures and clinic visits.1–3 Many such protocols
included examples of hierarchies for deﬁning elective,

1

AMITA Alexian Brothers Medical Center, USA
Departments of Radiology, Neurosurgery, and Neurology, Feinberg
School of Medicine, Northwestern University, USA
3
Interventional Neuroradiology, David Geffen School of Medicine,
University of California in Los Angeles, USA
4
Departments of Neurological Surgery and Radiology, Wake Forest
University, USA
5
Departments of Radiology and Biomedical Engineering, University of
California in San Francisco, USA
6
Department of Neurosurgery, Northshore University Hospital, USA
7
Department of Neurosurgery and Neuroscience Institute, Geisinger
Health System and Geisinger Commonwealth School of Medicine, USA
8
Research Institute of Neurointervention, Paracelsus Medical University,
Austria
9
Departments of Radiology and Neurosurgery, Albert Einstein College of
Medicine and Monteﬁore Medical Center, USA
10
Departments of Neurological Surgery, Neurology, Radiology, and
Neuroscience, University of Kentucky, USA
2

Corresponding author:
Tim W Malisch, AMITA Alexian Brothers Neuroscience Institute, Eberle
Bldg, Suite 610, 800 Biesterﬁeld Rd., Elk Grove Village, IL, USA.
Email: timothy.malisch@amitahealth.org

Malisch et al.
urgent, and emergent procedures; however, the examples
did not translate into clear guidance on the diverse array
of neurointerventional procedures.4
In the late spring and early summer of 2020 reports surfaced of morbidity and mortality rising in the nonhospitalized, non-COVID population, theorized to represent patients succumbing to urgent medical conditions
due either to avoidance of seeking medical care or a
delay in scheduled medical care.5,6 Reports also suggested
a corresponding decrease in patients presenting to emergency departments with symptoms of medical emergencies including neurovascular emergencies such as acute
stroke.7 Neurointerventional practices saw their volumes
of patients presenting within the time window for stroke
thrombectomy drop, despite a predicted increase in hypercoagulable complications in the COVID-19 population.8–
14
Ambulance services and law enforcement reports suggested an increase in calls for at-home medical deaths.7
These reports suggest that avoidance of medical facilities
is not without risk, elective medical care, and surgical procedures cannot be postponed indeﬁnitely, and eventually
many non-urgent conditions progress to urgent ones
requiring treatment.
As reports across the globe now indicate COVID-19
diagnoses are again climbing,15 we are faced with a new
wave of COVID-19 this winter, which may be exacerbated if coinciding with seasonal inﬂuenza, again straining
supplies of ICU beds, ventilators, resources, personnel,
and PPE.16 There is hope that the fatality rate of
COVID-19 may be lower with this wave due to new therapeutics, a better understanding of established drugs such
as steroids, delivery of supplemental oxygen without premature utilization or overutilization of ventilators, and
perhaps a shift in the COVID-19 population to younger
patients with fewer risk factors for an adverse outcome
from the disease. But the evidence does not suggest
fewer hospitalizations with this new wave of
COVID-19.17 Thoughtful action plans are required to
better address these issues. This document provides guidance during the COVID-19 pandemic, and future pandemics, on the cessation and resumption of elective
neurointerventional procedures that allocates scarce
resources and minimizes the risk of transmission of infection to patients, families, and health care providers while
enabling health care organizations to provide optimal
care to all the patients they serve. Although this pandemic
of COVID-19 will at some point pass, there is a clear need
to deﬁne prioritization of procedures and establishment of
safe neurointerventional workﬂows whenever regional
and institutional resources are strained.

Cessation and resumption of elective cases:
Timing at the local level
When considering whether the local health system or
institution can justify performance of elective, nonurgent neurointerventional procedures, institutions
should follow local, regional, state, and if applicable
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national regulations, and should consider these local
factors:
1. Pre-hospital resources and covid-19 screening:
Providing elective procedures during a pandemic
must minimize the risk of infecting those not infected
—including other patients, health providers and visitors.18–20 Screening patients and visitors in advance
of their hospital visit with risk factor screens
(Figure 1) and taking temperatures may be adequate
for clinic visits and procedures deﬁned not to be
aerosol generating procedures. Patients undergoing
aerosol generating procedures should be required to
undergo COVID-19 testing. With the global variation
in resources for COVID-19 testing, the type of test
required and the appropriate time window of the test
relative to the date of the procedure would likely be
deﬁned according to local availability.21–23 After a
patient is screened or tested, social distancing, and
mask wearing are recommended until the time of the
procedure.
2. In-hospital resources—Sufﬁcient for a surge in acutely
ill patients: The medical center must maintain adequate
resources to safely and effectively diagnose and treat
its current population of COVID-19 positive patients
and persons under investigation (PUI), as well as
anticipate an incremental volume of new cases
without risking shortage of supplies, beds, other hospital space, and personnel.24–27 Fortunately, most
elective neurointerventional procedure patients
require shorter lengths of stay and lower intensity of
care than the average severe COVID-19 patient.
3. In-hospital resources—Sufﬁcient to protect against
transmission: Hospital spaces to be shared by
COVID-19 positive, PUI patients and COVID-19
negative patients require resource and time-consuming
cleaning between patients. Workﬂows that minimize
cross-ﬂow of COVID-19 positive and negative patients
will be more efﬁcient but may not be feasible in smaller
institutions. When community COVID-19 levels
warrant concern about asymptomatic spreaders, then
in addition to screening visitors as discussed above,
public areas within the hospital available to visitors
should have sufﬁcient space to allow adequate social
distancing. Without the latter, performance of elective
procedures may need to be performed without allowing
visitors. This may also apply to clinic visits.

Prioritization of non-emergent procedures
It is recommended that both individual physician practices
and hospitals adopt a system of prioritization for performance of procedures, taking into account both the scarcity
of resources required for the procedure and the risk to the
patient in delaying the procedure. Such a protocol should
be transparent across clinical service lines and focused on
a comparative patient risk assessment. This facilitates an
open discussion among services that may need to share
resources. Several such categorization schemes have
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Figure 1. Checklist for elective neurointerventional radiology (NIR) procedures during pandemic.

been published which may serve as a foundation for such
discussions.27–30 We propose a tiered system that includes
examples speciﬁc to neurointerventional procedures
(Table 1).
In addition to categorizing resources utilized and
medical risks of delaying procedures, psychosocial and

ﬁnancial pressures facing patients while waiting for their
elective procedures must be considered.31 This is especially true for those who have lost, or are at risk of
losing, their source of income and insurance. Length of
time waiting in queue must also be considered due to its
psychological toll as well as an issue of fairness.

Table 1. Tiered system for case designation.
Tier

Designation Deﬁnition

Examples

1

Elective

No likelihood of medical harm from
delay

2

Urgent

Possible or likely serious medical
harm if delayed beyond 30 days

1.
2.
3.
4.
1.
2.
3.
4.

3

Emergent

Serious medical harm possible if any
delay

5.
6.
1.
2.

3.
4.
5.
a

Direct puncture sclerotherapy
Angioplasty/stenting for asymptomatic carotid atherosclerotic disease
Low risk intracranial aneurysm/vascular malformation
Late (>2 year) follow-up angiography for stable treated cerebral aneurysm
High risk unruptured intracranial aneurysm/vascular malformation
Unstable/symptomatic atherosclerotic disease
Tumor or infection requiring biopsy to guide management.
Tumor requiring preoperative angiography, balloon test occlusion, or
embolization for surgical planning/treatment
Dural arteriovenous ﬁstula with high-risk cortical venous drainage
Pain—minimally invasive spinal procedurea
Acute ischemic stroke/ELVO—mechanical thrombectomy
Acute intracranial hemorrhage (SAH/ICH/IVH/SDH) requiring diagnostic
angiography and/or endovascular treatment of ruptured aneurysm/
vascular malformation
New neurological deﬁcit/symptoms related to neurovascular pathology
requiring diagnostic angiography or endovascular treatment
Acute head and neck bleeding
Dural venous sinus thrombosis—thrombectomy

Immobility, reliance on narcotics, depression, or suicidal ideation associated with chronic severe pain represent serious confounding medical/psychological
issues that may render a case urgent, especially spinal pain procedures, vertebral augmentation, and minimally invasive spinal decompressive procedures.
ELVO: emergent large vessel occlusion; SAH: subarachnoid hemorrhage; ICH: intracerebral hemorrhage; IVH: intraventricular hemorrhage; SDH: subdural
hemorrhage.
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Operational logistics
An impartial hospital governing body or committee, consisting of representatives of hospital administration, and
representing the diversity of affected procedural service
lines may be necessary to adjudicate case priority status.
If such a governing body or committee is convened then
frequent communications between this body and scheduling physicians should be encouraged to promote transparency and to allow monitoring and reevaluation of cases
which may be changing in urgency.

Speciﬁc recommendations for
neurointerventional procedures
When the health system and applicable government and
regulatory authorities have conﬁrmed conditions and
resources are adequate for the performance of elective
cases and if necessary after cases have been prioritized,
the performance of these procedures may beneﬁt from
the following recommendations to safeguard both patients
and health care providers.32–35 Figure 1 is a printable
checklist that embodies the suggestions below. These suggestions are made recognizing the wide variation across
the globe with respect to both the burden of the pandemic
and resources available to provide care to patients in the
pandemic setting:

33
scheduling and again the morning of the procedure,
and conﬁrmation of both COVID-19 status and availability of anticipated post-procedural bed should be
included in the standard pre-procedural time-out.
4. Procedures should be performed as per the institution’s
standard protocols and COVID-19 policies, with
emphasis on enhanced PPE, appropriate donning and
dofﬁng of PPE, intubation of COVID-19 positive
patients in negative-pressure rooms if available and
post-procedural deep cleaning of procedural room
and time intervals between cases.

Conclusion
The COVID-19 pandemic has placed signiﬁcant strain on
health care systems around the globe. Neurointerventional
services are vital to patients. Delaying elective procedures
may be necessary when acutely ill COVID-19 patients
overwhelm resources, but delaying elective procedures
is not without risk. Health systems must develop coordinated protocols that deﬁne when elective cases can
safely be resumed and that promote safe performance
of elective neurointerventional procedures during a
pandemic.

Author contributions
1. Patients and family members should be educated regarding how undergoing an elective procedure in the pandemic setting affects their risk of becoming infected
during the hospital experience and also how their hospital experience may be impacted due to pandemicspeciﬁc requirements such as screening, testing, selfisolating, potential re-scheduling, and additional limitations on access to/by visitors. Patients should be given
the opportunity to delay the procedure, if desired, to
minimize this inconvenience or discomfort.
2. A formal scheme for screening patients should be
deﬁned, with screening recommended at time of scheduling the elective procedure, the day before the procedure, and the morning of the procedure. A formal
protocol should also be deﬁned for the type and
timing of COVID-19 testing for patients who display
any risk factors during the screenings, or have a temperature over the limit deﬁned by the institution and
any applicable regulatory agencies. Patients undergoing
aerosolizing procedures should receive the deﬁned type
and timing of COVID-19 testing as appropriate for that
region or locale. Any positive results of screening or
testing must be communicated between the scheduling
team, the procedural team, anesthesia, recovery room,
day surgery, and/or post-procedural units as indicated.
Consensus should be reached on whether to continue
with an elective procedure on a COVID-19 positive or
PUI patient, utilizing the hospital’s COVID-19 protocols, or whether to reschedule the procedure.
3. The procedural team should conﬁrm post-procedural
ICU/hospital bed space availability at the time of
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